Home › Compare › Wegovy vs Mounjaro
Wegovy vs Mounjaro in South Africa
How Wegovy (semaglutide) and Mounjaro (tirzepatide) compare on cost, dosing and what they're approved for.
| Wegovy | Mounjaro | |
|---|---|---|
| Active ingredient | semaglutide | tirzepatide |
| How often | once weekly | once weekly |
| Monthly cost | R1 800–R3 700 | R2 800–R5 500 |
| Approved for | Registered specifically for weight management (higher-dose semaglutide) | Dual-action (GIP/GLP-1) for type 2 diabetes and weight management |
| Medical aid | Not typically covered — obesity is not classified as a chronic condition by most SA schemes | Generally not covered for weight loss; diabetes use may qualify on application |
Wegovy
Same active ingredient as Ozempic (semaglutide) but dosed and registered for weight loss, titrating up to 2.4 mg weekly. Novo Nordisk recently cut its SA prices, making the starting doses more competitive.
Wegovy detailsMounjaro
The newer tirzepatide option, often cited for strong results. Distributed by Aspen in SA as single-dose vials (a KwikPen is under SAHPRA evaluation); a typical month is about R4 000 for four vials.
Mounjaro detailsFrequently asked questions
Is Wegovy or Mounjaro better for weight loss?
What is the price difference between Wegovy and Mounjaro in South Africa?
Can I switch from Wegovy to Mounjaro?
Sources: South African Health Products Regulatory Authority (SAHPRA) registration data, the approved package inserts, and public pharmacy price listings. Last reviewed 2026-05-30. No information here is medical advice.